Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 21, 2003. The report primarily details changes in directors' interests in the company's Ordinary Shares and confirms the submission of resolutions passed at the Annual General Meeting (AGM) held on May 19, 2003.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and equity transactions rather than financial performance.
Material Changes
The filing reports specific transactions involving the GlaxoSmithKline Employee Trust ("GSK Trust") and employee incentive plans:
- May 16, 2003: The GSK Trust sold 17,354 Ordinary Shares on behalf of a participant in the SmithKline Beecham Mid Term Incentive Plan at a price of £13.33 per share.
- May 16, 2003: The GSK Trust transferred 17,559 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- May 19, 2003: The GSK Trust transferred 4,004 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Directors Dr J-P Garnier and Mr J D Coombe hold interests in the shares held by the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that resolutions passed as special business at the AGM on May 19, 2003, have been submitted to the UKLA and will be available via the Financial Services Authority.
Investor Verification Checklist
- Verify the total number of shares held by the GSK Trust following the reported sales and transfers.
- Confirm the specific resolutions passed at the AGM on May 19, 2003, via the UKLA document viewing facility.
- Review the full terms of the SmithKline Beecham Mid Term Incentive Plan and Employee Share Option Plan 1991 to understand the context of the share movements.
- Check subsequent filings for the company's actual financial performance for the period, as this document does not contain financial statements.